Clidinium-d5 (bromide)

Clidinium-d5 (bromide)

• UNSPSC Description: Clidinium-d5 (bromide) is the deuterium labeled Clidinium bromide. Clidinium bromide is a quaternary amine antimuscarinic agent[1].
• Target Antigen: Isotope-Labeled Compounds; mAChR
• Type: Isotope-Labeled Compounds
• Related Pathways: GPCR/G Protein;Neuronal Signaling;Others
• Applications: Neuroscience-Neuromodulation
• Field of Research: Neurological Disease
• Solubility: 10 mM in DMSO
• Smiles: C[N+]1(CC2)CC(OC(C(C3=CC=CC=C3)(O)C4=C([2H])C([2H])=C([2H])C([2H])=C4[2H])=O)C2CC1.[Br-]
• Molecular Weight: 437.38
• References & Citations: [1]Leila Moezi, et al. Constipation Enhances the Propensity to Seizure in Pentylenetetrazole-Induced Seizure Models of Mice. Epilepsy Behav
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported